June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Forecasting Risk of Future Rapid Glaucoma Worsening Using Early Visual Field, Optical Coherence Tomography and Clinical Data
Author Affiliations & Notes
  • Patrick Herbert
    Johns Hopkins University, Baltimore, Maryland, United States
  • Kaihua Hou
    Johns Hopkins University, Baltimore, Maryland, United States
  • Chris Bradley
    Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
  • Michael V Boland
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Pradeep Y Ramulu
    Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
  • Mathias Unberath
    Johns Hopkins University, Baltimore, Maryland, United States
  • Jithin Yohannan
    Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
    Johns Hopkins University Whiting School of Engineering, Baltimore, Maryland, United States
  • Footnotes
    Commercial Relationships   Patrick Herbert None; Kaihua Hou None; Chris Bradley None; Michael Boland Zeiss, Code C (Consultant/Contractor); Pradeep Ramulu Heru Inc., Code C (Consultant/Contractor); Mathias Unberath None; Jithin Yohannan None
  • Footnotes
    Support  5 K23 EY032204-02
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2294. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Patrick Herbert, Kaihua Hou, Chris Bradley, Michael V Boland, Pradeep Y Ramulu, Mathias Unberath, Jithin Yohannan; Forecasting Risk of Future Rapid Glaucoma Worsening Using Early Visual Field, Optical Coherence Tomography and Clinical Data. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2294.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We assess whether we can forecast future rapid visual field (VF) worsening using deep learning models (DLM) trained on baseline VF, OCT, and clinical data. Additionally, we study the impact of adding additional VF data (beyond baseline) on model performance.

Methods : We included eyes that met the following: 1) followed for glaucoma or suspect status 2) had at least five reliable VFs over time (VF1, VF2, VF3, VF4, VF5) 3) had one reliable baseline OCT scan (OCT1) and one set of baseline clinical measurement: age, gender, BCVA, IOP (Clinical1) at the time of VF1.
We designed a DLM to detect eyes at risk for future rapid VF worsening (mean deviation (MD) slope <-1 dB/yr across all five VFs). The input to the DLM consisted of spatially oriented total deviation values from VF1 (+/- VF2 and VF3 in some models) and spatially oriented RNFL thickness values from OCT1 (Figure 1A). We input this VF/OCT stack into a vision transformer feature extractor. The output of the feature extractor was concatenated with Clinical1 and put through a dense linear classifier to make a final prediction for that eyes’ risk of future rapid VF worsening (Figure 1B). We used 80% of data for training, 10% for validation, and 10% for testing.
We compared the performance of models with differing inputs by computing area under receiver operating curve (AUC) in the test set. Specifically, we trained models with following inputs: Model (1) VF1; (2) VF1+ Clinical1; (3) VF1+ OCT1; (4) VF1+ Clinical1+ OCT1; (5) VF1 + VF2 + Clinical1 + OCT1; (6) VF1 + VF2 + VF3, + Clinical1 + OCT1

Results : We included a total of 4,537 unique eyes from 2,963 patients. Mean and (SD) for: age | VF MD at baseline | MD slope, was: 65.9 years (12.4) | -3.4 dB (4.3) | -0.21 dB/yr (1.0). 518 (11.4%) of eyes underwent rapid VF worsening. Model 6 most accurately forecasted rapid worsening with an AUC (95% CI) of 0.85 (0.78, 0.93). Remaining models in descending order of performance and their respective AUC [95% CI] were: Model 5 (0.81 [0.73 to 0.89]), Model 4 (0.75 [0.66, 0.83]), Model 2 [0.75 [0.66, 0.83], Model 3 (0.71 [0.62, 0.80]), Model 1 (0.68 [0.59, 0.77]).

Conclusions : DLMs trained on multimodal data from early visits can forecast future rapid worsening with AUC >0.8. Deployment of such models in clinical practice may allow us to stratify high from low-risk glaucoma patients early in the disease course.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×